Related references
Note: Only part of the references are listed.Selective CB2 inverse agonist JTE907 drives T cell differentiation towards a Treg cell phenotype and ameliorates inflammation in a mouse model of inflammatory bowel disease
Marco Gentili et al.
PHARMACOLOGICAL RESEARCH (2019)
Active metabolites of dipyrone induce a redox-dependent activation of the ion channels TRPA1 and TRPV1
Stefan Alexander Schenk et al.
PAIN REPORTS (2019)
Synthesis of new lophine-carbohydrate hybrids as cholinesterase inhibitors: cytotoxicity evaluation and molecular modeling
Joao Paulo Bizarro Lopes et al.
MEDCHEMCOMM (2019)
Monoacylglycerol lipase regulates cannabinoid receptor 2-dependent macrophage activation and cancer progression
Wei Xiang et al.
NATURE COMMUNICATIONS (2018)
Systematic Study of Effects of Structural Modifications on the Aqueous Solubility of Drug-like Molecules
Jose A. Cisneros et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Design, Synthesis, and Pharmacological Evaluation of Novel N-Acylhydrazone Derivatives as Potent Histone Deacetylase 6/8 Dual Inhibitors
Daniel A. Rodrigues et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders
Gemma Navarro et al.
FRONTIERS IN NEUROSCIENCE (2016)
Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites
Caroline Turcotte et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist
Chaela Presley et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2015)
The analgesic effect of dipyrone in peripheral tissue involves two different mechanisms: Neuronal KATP channel opening and CB1 receptor activation
Gilson Goncalves dos Santos et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Inhibition of Endocannabinoid Metabolism by the Metabolites of Ibuprofen and Flurbiprofen
Jessica Karlsson et al.
PLOS ONE (2014)
Novel bioactive metabolites of dipyrone (metamizol)
Tobias Rogosch et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Chromenopyrazoles: Non-psychoactive and Selective CB1 Cannabinoid Agonists with Peripheral Antinociceptive Properties
Jose Cumella et al.
CHEMMEDCHEM (2012)
Metamizol, a non-opioid analgesic, acts via endocannabinoids in the PAG-RVM axis during inflammation in rats
W. Escobar et al.
EUROPEAN JOURNAL OF PAIN (2012)
5-Imino-1,2-4-thiadiazoles and quinazolines derivatives as glycogen synthase kinase 3β (GSK-3β) and phosphodiesterase 7 (PDE7) inhibitors: Determination of blood-brain barrier penetration and binding to human serum albumin
Daniel I. Perez et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Optimization of a parallel artificial membrane permeability assay for the fast and simultaneous prediction of human intestinal absorption and plasma protein binding of drug candidates: Application to dibenz[b,f]azepine-5-carboxamide derivatives
Ana Fortuna et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2
Kelsey C. Duggan et al.
NATURE CHEMICAL BIOLOGY (2011)
The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects
Steven G. Kinsey et al.
NEUROPHARMACOLOGY (2011)
Centrally mediated antinociceptive effects of cannabinoid receptor ligands in rat models of nociception
Aldric Hama et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2011)
Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain
V. Curto-Reyes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Antinociceptive effect of the cannabinoid agonist, WIN 55,212-2, in the orofacial and temporomandibular formalin tests
Elisa Burgos et al.
EUROPEAN JOURNAL OF PAIN (2010)
In vitro and in vivo pharmacological characterization of two novel selective cannabinoid CB2 receptor inverse agonists
Maria Grazia Cascio et al.
PHARMACOLOGICAL RESEARCH (2010)
Regulation of Inflammatory Pain by Inhibition of Fatty Acid Amide Hydrolase
Pattipati S. Naidu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression
Fabricio A. Moreira et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain
Kay Ahn et al.
CHEMISTRY & BIOLOGY (2009)
The Endocannabinoid System and Pain
Josee Guindon et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
Drug-Like Property Concepts in Pharmaceutical Design
Li Di et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside
Elizabeth J. Rahn et al.
NEUROTHERAPEUTICS (2009)
Rapid solubility determination of the triterpenes oleanolic acid and ursolic acid by UV-spectroscopy in different solvents
P. Schneider et al.
PHYTOCHEMISTRY LETTERS (2009)
Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain
J. Guindon et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Biology and therapeutic potential of cannabinoid CB2 receptor inverse agonists
C. A. Lunn et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
In vitro plasma stability, permeability and solubility of mercaptoacetamide histone deacetylase inhibitors
Roula Konsoula et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
A novel design of artificial membrane for improving the PAMPA model
Xiaoxi Chen et al.
PHARMACEUTICAL RESEARCH (2008)
The inhibition of monoacylglycerol lipase by URB602 showed an anti-inflammatory and anti-nociceptive effect in a murine model of acute inflammation
F. Comelli et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Dipyrone elicits substantial inhibition of peripheral cyclooxygenases in humans: new insights into the pharmacology of an old analgesic
Burkhard Hinz et al.
FASEB JOURNAL (2007)
The antinociceptive effects of intraplantar injections of 2-arachidonoyl glycerol are mediated by cannabinoid CB2 receptors
J. Guindon et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Antinociceptive activity of Amazonian Copaiba oils
Niele Matos Gomes et al.
JOURNAL OF ETHNOPHARMACOLOGY (2007)
Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors
S Maione et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Amide bond formation and peptide coupling
CAGN Montalbetti et al.
TETRAHEDRON (2005)
Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats
DP Finn et al.
NEUROPHARMACOLOGY (2003)
Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors
E Hermans
PHARMACOLOGY & THERAPEUTICS (2003)
High throughput artificial membrane permeability assay for blood-brain barrier
L Di et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2003)
A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential
CY Zhu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2002)
Molecular probes for the cannabinoid receptors
AD Khanolkar et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2000)
The productive conformation of arachidonic acid bound to prostaglandin synthase
MG Malkowski et al.
SCIENCE (2000)
Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat
P Beaulieu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Share Paper
